Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anaplastic large cell lymphoma: a clinicopathologic analysis.

B F Skinnider1, J M Connors, S B Sutcliffe

  • 1Department of Pathology, British Columbia Cancer Agency, Vancouver, Canada.

Hematological Oncology
|March 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 2022 ITAC evidence-based clinical practice guidelines: New update from the International Initiative on Thrombosis and Cancer to improve the care in patients with cancer-associated thrombosis.

Journal de medecine vasculaire·2022
Same author

Cancer and thrombosis: new insights to an old problem.

Journal de medecine vasculaire·2020
Same author

Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis.

Journal de medecine vasculaire·2020
Same author

New progress in the treatment and prophylaxis of venous thrombo-embolism in cancer patients.

Journal de medecine vasculaire·2020
Same author

Hodgkin lymphoma, treatment and thrombosis: a dangerous mix.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Observation as the initial management strategy in patients with mantle cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Anaplastic large cell lymphoma (ALCL) classification is improved by identifying distinct subtypes. Detecting the NPM-ALK fusion protein aids in distinguishing ALCL subtypes with different prognoses, crucial for patient outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Anaplastic large cell lymphoma (ALCL) is a heterogeneous group of T-cell lymphomas.
  • Histologic examination alone is insufficient for accurate prognostication in ALCL.
  • Distinguishing ALCL subtypes is critical for determining appropriate patient management and predicting outcomes.

Purpose of the Study:

  • To review the clinicopathologic features of ALCL.
  • To highlight the importance of integrating clinical, phenotypic, and genotypic data for ALCL classification.
  • To emphasize the diagnostic and prognostic significance of the t(2;5) translocation and NPM-ALK fusion protein.

Main Methods:

  • Review of existing literature on ALCL clinicopathologic features.
  • Discussion of diagnostic methods including immunohistochemistry for ALK protein detection.

Related Experiment Videos

  • Correlation of genetic findings (t(2;5) translocation) with clinical presentation and prognosis.

    • Main Results:

    • Several distinct clinicopathologic entities within ALCL have been identified.
    • A subset of ALCL is characterized by the t(2;5) translocation, leading to the NPM-ALK fusion protein.
    • Detection of ALK protein is a key marker for a distinct ALCL biologic entity with significant prognostic implications.

    Conclusions:

    • The identification of ALK-positive ALCL represents a significant advancement in understanding ALCL heterogeneity.
    • ALK-negative ALCL generally carries a poorer prognosis compared to ALK-positive ALCL.
    • Primary cutaneous ALCL has an excellent prognosis and should be differentiated from systemic ALCL subtypes.